A biomarker for a cellular switch that accurately predicts which prostate cancer patients are likely to have their cancer recur or spread has been identified by researchers at Vanderbilt University Medical Center and the University of Alberta in Canada. The study, posted online recently in advance of publication in iCancer Research/i, was led by co-investigators Andries Zijlstra, Ph.D., assistant professor of Pathology, Microbiology and Immunology and Cancer ...
Read More
No comments:
Post a Comment